Apollo Endosurgery Inc.

3.68-0.1200-3.16%Vol 188.01K1Y Perf -55.08%
Jun 24th, 2022 16:00 DELAYED
BID1.46 ASK5.80
Open3.79 Previous Close3.80
Pre-Market- After-Market-
 - -  - -%
Target Price
11.00 
Analyst Rating
Strong Buy 1.00
Potential %
198.91 
Finscreener Ranking
★★★+     51.10
Insiders Trans % 3/6/12 mo.
-/100/40 
Value Ranking
★★     46.47
Insiders Value % 3/6/12 mo.
-/100/84 
Growth Ranking
     37.83
Insiders Shares Cnt. % 3/6/12 mo.
-/100/84 
Income Ranking
 —    -
Price Range Ratio 52W %
2.33 
Earnings Rating
Strong Buy
Market Cap148.12M 
Earnings Date
2nd Aug 2022
Alpha-0.01 Standard Deviation0.28
Beta2.28 

Today's Price Range

3.563.83

52W Range

3.5210.39

5 Year PE Ratio Range

-3.20-0.2000

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-0.81%
1 Month
-12.59%
3 Months
-43.30%
6 Months
-53.06%
1 Year
-55.08%
3 Years
7.60%
5 Years
-51.64%
10 Years
-99.12%

TickerPriceChg.Chg.%
APEN3.68-0.1200-3.16
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
6.70
7.80
0.49
0.98
-2.40
Leverage Ratio 3.40
ProfitabilityValueIndustryS&P 500US Markets
56.00
-30.40
-25.80
-57.70
-43.31
RevenueValueIndustryS&P 500US Markets
65.79M
1.63
3.31
-5.32
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.21-0.210.00
Q04 2021-0.20-0.27-35.00
Q03 2021-0.30-0.2323.33
Q02 2021-0.17-0.1135.29
Q01 2021-0.19-0.1710.53
Q04 2020-0.21-0.1433.33
Q03 2020-0.17-0.1135.29
Q02 2020-0.23-0.30-30.43
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.2112.50Positive
9/2022 QR-0.2314.81Positive
12/2022 FY-0.843.45Positive
12/2023 FY-0.774.94Positive
Next Report Date2nd Aug 2022
Estimated EPS Next Report-0.21
Estimates Count3
EPS Growth Next 5 Years %7.00
Volume Overview
Volume188.01K
Shares Outstanding40.25K
Shares Float33.98M
Trades Count2.29K
Dollar Volume693.78K
Avg. Volume93.64K
Avg. Weekly Volume71.09K
Avg. Monthly Volume86.50K
Avg. Quarterly Volume123.32K

Apollo Endosurgery Inc. (NASDAQ: APEN) stock closed at 3.68 per share at the end of the most recent trading day (a -3.16% change compared to the prior day closing price) with a volume of 188.01K shares and market capitalization of 148.12M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 217 people. Apollo Endosurgery Inc. CEO is K. Todd Newton.

The one-year performance of Apollo Endosurgery Inc. stock is -55.08%, while year-to-date (YTD) performance is -56.35%. APEN stock has a five-year performance of -51.64%. Its 52-week range is between 3.52 and 10.39, which gives APEN stock a 52-week price range ratio of 2.33%

Apollo Endosurgery Inc. currently has a PE ratio of -4.40, a price-to-book (PB) ratio of 2.71, a price-to-sale (PS) ratio of 2.27, a price to cashflow ratio of 6.00, a PEG ratio of 2.32, a ROA of -28.64%, a ROC of -27.83% and a ROE of -98.73%. The company’s profit margin is -43.31%, its EBITDA margin is -25.80%, and its revenue ttm is $65.79 Million , which makes it $1.63 revenue per share.

Of the last four earnings reports from Apollo Endosurgery Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.21 for the next earnings report. Apollo Endosurgery Inc.’s next earnings report date is 02nd Aug 2022.

The consensus rating of Wall Street analysts for Apollo Endosurgery Inc. is Strong Buy (1), with a target price of $11, which is +198.91% compared to the current price. The earnings rating for Apollo Endosurgery Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Apollo Endosurgery Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Apollo Endosurgery Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 32.88, ATR14 : 0.31, CCI20 : -109.61, Chaikin Money Flow : -0.02, MACD : -0.25, Money Flow Index : 40.48, ROC : -17.86, RSI : 35.44, STOCH (14,3) : 11.85, STOCH RSI : 0.59, UO : 40.48, Williams %R : -88.15), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Apollo Endosurgery Inc. in the last 12-months were: Charles McKhann (Sold 63 452 shares of value $504 234 ), Jeffrey G. Black (Buy at a value of $447 850), R. Kent McGaughy (Buy at a value of $5 300 000)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
5 (100.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Apollo Endosurgery Inc.

Apollo Endosurgery Inc is active in the healthcare sector based in the United States. As a developer of medical devices, Apollo focusses on addressing obesity, as well as other gastrointestinal disorders. Its products are used by general surgeons, bariatric surgeons and gastroenterologists in a variety of settings to provide interventional therapy to patients who suffer from obesity. The company's products include ORBERA, LAP-BAND and OverStitch.

CEO: K. Todd Newton

Telephone: +1 512 279-5100

Address: 1120 S. Capital of Texas Highway, Austin 78746, TX, US

Number of employees: 217

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

66%34%

Bearish Bullish

63%37%

TipRanks News for APEN

News

Stocktwits